SELECTBIO Conferences Cell Therapy Asia 2018
Cell Therapy Asia 2018
Date: December 6 - 7, 2018
Venue: Kobe, Japan

Conference Chairs

Yuzo Toda

Yuzo Toda
President, FIRM (Forum for Innovative Regenerative Medicine, Japan)

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Keynote Speakers

Keisuke Goda

Keisuke Goda
Professor of Physical Chemistry, University of Tokyo, ImPACT Program Manager, Japan Science and Technology Agency

Kunihiko Suzuki

Kunihiko Suzuki
Vice Chairman & Member of the Board, Medinet Co. Ltd., Vice Chair, Forum for Innovative Regenerative Medicine (FIRM)

Michael Bennett

Michael Bennett
Director of Business Development, Cell and Gene Therapy Catapult

Yoshitsugu Shitaka

Yoshitsugu Shitaka
President, Astellas Institute for Regenerative Medicine

Masayo Takahashi

Masayo Takahashi
Professor, RIKEN Center for Biosystems Dynamics Research

Hiromitsu Nakauchi

Hiromitsu Nakauchi
Prof of Genetics, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine Project Professor, The Institute of Medical Science, Division of Stem Cell Therapy, Distinguished Professor Unit, The University of Tokyo

Shoji Takeuchi

Shoji Takeuchi
Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo

Terry Riss

Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation

Hideyuki Okano

Hideyuki Okano
Professor, Department of Physiology, Keio University School of Medicine


SELECTBIO is pleased to welcome you to Cell Therapy Asia 2018 which will be held in Kobe, Japan.

This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application.

The conference addresses the whole ecosystem of Cell Therapy and Tissue Engineering with a focus on 3D-Culture, Organoids, Microfluidics technologies for constructing microphysiological systems.

In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan.

With its strong biomedical research infrastructure, Kobe Japan is a perfect venue for Cell Therapy Asia 2018.

SELECTBIO is honored that Professor Norio Nakatsuji, Professor Emeritus Kyoto University will be leading the conference and invites young scientists to submit poster abstracts to the conference. From these poster abstracts, the scientific leadership team of the conference will pick outstanding abstracts for oral presentations.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 30 November 2018

Agenda Topics

  • 3D-Culture and Organoids
  • Clinical Trials and Commercialization of Cell Therapies
  • Cord Blood and Cord Blood-Derived Stem Cells for Cellular Therapy
  • Emerging Technologies and Emerging Companies Showcase
  • Immuno-Oncology (IO)
    • CAR-T Cells for Cancer Therapy
  • iPSC-derived Cells for Toxicity Testing, Screening and Cellular Therapy
  • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
  • Microfluidics Platforms for Building Microphysiological Systems Ex Vivo
  • Regulatory Landscape for Cellular Therapy
  • Stem Cell-derived Exosomes with Regenerative Potential
  • Stem Cells for Cellular Therapy
  • Tissue Engineering

Sponsorship and Exhibition Opportunities

For more details, please contact us.

Confirmed Speakers to date

Shizuka Akieda, Chief Executive Officer, Cyfuse Biomedical K.K.
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Tatsuo Heki, Senior Expert, Regenerative Medicine Division, Fujifilm Corporation
Shin-Il Kim, Director, Division of Research & Development, aceRNA Technologies Co., Ltd.
Thasaneeya Kuboki, Assistant Professor, Laboratory of Biomedical and Biophysical Chemistry, Institute for Materials Chemistry and Engineering, Kyushu University
Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Hirofumi Suemori, Associate Professor, Laboratory of Embryonic Stem Cell Research, Institute for Frontier Life and Medical Sciences, Kyoto University
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
William G Whitford, Strategic Solutions Leader Bioprocess, GE Healthcare Life Sciences

Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Traditional Chinese
Simplified Chinese